3.4748
price up icon2.44%   0.0827
after-market アフターアワーズ: 3.47 -0.0048 -0.14%
loading
前日終値:
$3.3921
開ける:
$3.3101
24時間の取引高:
2,840
Relative Volume:
0.14
時価総額:
$501.40M
収益:
$16.82M
当期純損益:
$-112.19M
株価収益率:
-1.5664
EPS:
-2.2183
ネットキャッシュフロー:
$-91.84M
1週間 パフォーマンス:
-3.61%
1か月 パフォーマンス:
-3.06%
6か月 パフォーマンス:
+41.83%
1年 パフォーマンス:
+9.96%
1日の値動き範囲:
Value
$3.3101
$3.4748
1週間の範囲:
Value
$3.30
$3.8234
52週間の値動き範囲:
Value
$1.53
$4.05

Inventiva Adr Stock (IVA) Company Profile

Name
名前
Inventiva Adr
Name
セクター
Healthcare (1168)
Name
電話
-
Name
住所
-
Name
職員
118
Name
Twitter
Name
次回の収益日
2025-03-26
Name
最新のSEC提出書
Name
IVA's Discussions on Twitter

IVA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
IVA
Inventiva Adr
3.4748 501.40M 16.82M -112.19M -91.84M -2.2183
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
455.45 115.69B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
529.24 53.25B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
307.99 39.22B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
577.89 35.78B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
269.63 27.68B 3.81B -644.79M -669.77M -6.24

Inventiva Adr Stock (IVA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-02-21 開始されました TD Cowen Buy
2024-11-12 開始されました UBS Neutral
2023-10-27 開始されました Canaccord Genuity Buy
2023-05-31 開始されました ROTH MKM Buy
2023-05-19 アップグレード Societe Generale Sell → Buy
2023-03-17 開始されました Stifel Buy
2022-11-15 ダウングレード Societe Generale Buy → Sell
2021-03-08 ダウングレード Societe Generale Buy → Sell
2020-08-05 開始されました ROTH Capital Buy
2020-08-04 開始されました Guggenheim Buy
2020-08-04 開始されました Stifel Buy
すべてを表示

Inventiva Adr (IVA) 最新ニュース

pulisher
Jun 06, 2025

Inventiva (IVA) Upgraded to Buy: What Does It Mean for the Stock? - MSN

Jun 06, 2025
pulisher
May 27, 2025

Inventiva Participera à la « Jefferies Global Healthcare Conference » et à la « UBS Spring Biotech Conference » - GlobeNewswire Inc.

May 27, 2025
pulisher
Apr 04, 2025

Is Elicio Therapeutics, Inc. (ELTX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Apr 04, 2025
pulisher
Apr 02, 2025

Inventiva achieves milestone with Phase 3 study enrollment, says H.C. Wainwright - TipRanks

Apr 02, 2025
pulisher
Apr 02, 2025

Stifel maintains Buy on Inventiva shares with $17 target - Investing.com

Apr 02, 2025
pulisher
Mar 28, 2025

Inventiva SA ADR Reports 2024 Financial Results and Strategic Updates - TipRanks

Mar 28, 2025
pulisher
Mar 26, 2025

Inventiva earnings missed by $0.03, revenue topped estimates - Investing.com

Mar 26, 2025
pulisher
Jan 30, 2025

Top 10 Best Indian Companies In Smart Grids Solutions 2025 - Inventiva

Jan 30, 2025
pulisher
Oct 14, 2024

Stifel reiterates Buy rating on Inventiva stock, cites financing deal - Investing.com

Oct 14, 2024
pulisher
Oct 01, 2024

Inventiva (IVA) Loses -17.66% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

Oct 01, 2024
pulisher
Aug 28, 2024

Why Are Criminals Still in Power? 151 Lawmakers with Charges of Crimes Against Women Continue to Hold Office! Is This the End of Integrity in Indian Politics? - inventiva.co.in

Aug 28, 2024
pulisher
Jun 18, 2024

Down -27.95% in 4 Weeks, Here's Why You Should You Buy the Dip in Inventiva (IVA) - Nasdaq

Jun 18, 2024
pulisher
Apr 24, 2024

NOTA, No Votes and Unopposed Nominations: The Grey Areas of the Indian Election Process Explained - inventiva.co.in

Apr 24, 2024
pulisher
Feb 12, 2024

symbol__ Stock Quote Price and Forecast - CNN

Feb 12, 2024
pulisher
Oct 10, 2023

Supreme Court To Hear Plea Against Electoral Bonds From October 31 - Inventiva

Oct 10, 2023
pulisher
Mar 06, 2023

Top 10 Best Handicraft Companies In USA 2023 - inventiva.co.in

Mar 06, 2023
pulisher
Feb 22, 2023

Top 20 Best Hardware & Networking Company In India 2023 - inventiva.co.in

Feb 22, 2023
pulisher
Oct 03, 2021

Inventiva SaAdr Share Price Today (NASDAQ: IVA)Inventiva SaAdr Stock Price Live Quote - INDmoney

Oct 03, 2021
pulisher
Jan 20, 2021

The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - Yahoo Finance

Jan 20, 2021

Inventiva Adr (IVA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$98.73
price up icon 1.91%
$22.82
price down icon 1.17%
$34.84
price down icon 1.22%
$19.78
price down icon 1.88%
$106.57
price up icon 1.57%
biotechnology ONC
$269.63
price down icon 2.50%
大文字化:     |  ボリューム (24 時間):